NGL Fine-Chem (NGLFINE) Stock Overview

NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for use in veterinary and human health worldwide. It offers active pharmaceutical ingredients, such as diminazene aceturate, diminazene diaceturate, homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, ractopamine HCl, S-methoprene, praziquantel, toltrazuril, decoquinate, flunixin meglumine, carprofen, fenbendazole, amitraz, xylazine hydrochloride, and marbofloxacin for animal health applications; and nitazoxanide and atovaquone for human health applications. The company provides various intermediate products and specialty chemicals; and finished dosage forms in granules and tablets. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India.

NGLFINE Stock Information

Symbol

NGLFINE

Address

301, E SquareMumbai, 400057India

Founded

Trading hours

Website

https://www.nglfinechem.com

Country

🇮🇳 India

Phone Number

91 22 4084 2222

NGL Fine-Chem (NGLFINE) Price Chart

NGL Fine-Chem Overview: Key Details and Summary

Stock data	2023	Change
Price	$25.13	N/A
Market Cap	$155.22M	N/A
Shares Outstanding	6.18M	-0.01%
Employees	396.00	N/A
Shareholder Equity	2.23B	9.51%

Valuation	2023	Change
P/E Ratio	0.76	N/A
P/S Ratio	4.69	N/A
P/B Ratio	0.07	N/A

Growth	2023	Change
Return on Equity	0.0011	N/A

Earnings	2023	Change
Revenue	$33.11M	N/A
Earnings	$2.44M	N/A
EPS	33.18	N/A
Earnings Yield	1.32	N/A
Gross Margin	0.4954	N/A
Operating Margin	0.0828	N/A
Net income margin	0.0737	N/A

Financial Strength	2023	Change
Total Assets	$34.18M	N/A
Total Debt	$3.63M	N/A
Cash on Hand	$6.85M	N/A
Debt to Equity	0.0035	-20.06%
Cash to Debt	$1.89	85.51%
Current Ratio	$2.79	5.59%